Madrigal Pharmaceuticals, Inc.

NASDAQ (USD): Madrigal Pharmaceuticals, Inc. (MDGL)

Last Price

302.93

Today's Change

+9.52 (3.24%)

Day's Change

293.00 - 312.52

Trading Volume

291,337

Overview

Market Cap

6 Billion

Shares Outstanding

21 Million

Avg Volume

420,309

Avg Price (50 Days)

286.92

Avg Price (200 Days)

256.70

PE Ratio

-12.10

EPS

-25.03

Earnings Announcement

26-Feb-2025

Previous Close

293.41

Open

294.00

Day's Range

293.0 - 312.5199

Year Range

168.25 - 368.29

Trading Volume

291,534

Price Change Highlight

1 Day Change

3.25%

5 Day Change

0.60%

1 Month Change

-4.46%

3 Month Change

29.74%

6 Month Change

13.12%

Ytd Change

33.53%

1 Year Change

37.05%

3 Year Change

279.14%

5 Year Change

238.36%

10 Year Change

215.89%

Max Change

-4.78%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment